Open Beta
MetriLume

US marketsCDIO

SEC-sourced researchBeta

CDIO

Cardio Diagnostics Holdings, Inc.

Company comparison ↗

Data passport

CIK
0001870144
Exchange
Nasdaq
Business activity
In Vitro & In Vivo Diagnostic Substances · SIC 2835
Financial inputs
6/6
Filing date
Nov 6, 2026
SEC registry record
Operating company

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 34,890.0000 USD; December 2025: 14,825.0000 USD34.9K USD0 USD0December 2024December 2025
CDIO · Exact amounts and source periods · USD
Period endRevenueFiling date
December 202434,890.0000Mar 13, 2026
December 202514,825.0000Mar 13, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 202514,825.0000-6,498,167.0000-5,726,833.00007,766,415.0000793,061.0000Mar 13, 2026
December 202434,890.0000-8,383,453.0000-4,993,104.000010,615,312.00001,057,524.0000Mar 13, 2026

Explainable fundamental score

Five equally weighted components based on SEC financial inputs. No price inputs or personal investment preferences.

38/100
Profitability0
Growth0
Balance sheet90
Cash generation0
Data coverage100

Component weight: 20% · Minimum data coverage: 50% · Missing component value: 50/100

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenues$14.83KJan 1, 2025 – Dec 31, 2025Mar 13, 202610-K
Previous period revenueRevenues$34.89KJan 1, 2024 – Dec 31, 2024Mar 13, 202610-K
Net incomeNetIncomeLoss-$6.5MJan 1, 2025 – Dec 31, 2025Mar 13, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$5.73MJan 1, 2025 – Dec 31, 2025Mar 13, 202610-K
Total assetsAssets$7.77MDec 31, 2025Mar 13, 202610-K
Total liabilitiesLiabilities$793.06KDec 31, 2025Mar 13, 202610-K

New filings

Explore methodology ↗